journal article·2025-02

Cyclic catalysis of intratumor Fe3+/2+ initiated by a hollow mesoporous iron sesquioxide nanoparticle for ferroptosis therapy of large tumors

Jing Yang, Bin Ren, Haobin Cai, Wei Xiong, Jie Feng, Qingdeng Fan, Zongheng Li, Lin Huang, Chenggong Yan, Yan Li, Chaomin Chen, Zheyu Shen

Biomaterials· Volume 313
Publisher page

Abstract

Numerous nanoparticles have been utilized to deliver Fe2+ for tumor ferroptosis therapy, which can be readily converted to Fe3+via Fenton reactions to generate hydroxyl radical (•OH). However, the ferroptosis therapeutic efficacy of large tumors is limited due to the slow conversion of Fe3+ to Fe2+via Fenton reactions. Herein, a strategy of intratumor Fe3+/2+ cyclic catalysis is proposed for ferroptosis therapy of large tumors, which was realized based on our newly developed hollow mesoporous iron sesquioxide nanoparticle (HMISN). Cisplatin (CDDP) and Gd-poly(acrylic acid) macrochelates (GP) were loaded into the hollow core of HMISN, whose surface was modified by laccase (LAC). Fe3+, CDDP, GP, and LAC can be gradually released from CDDP@GP@HMISN@LAC in the acidic tumor microenvironment. The intratumor O2 can be catalyzed into superoxide anion (O2•-) by LAC, and the intratumor NADPH oxidases can be activated by CDDP to generate O2•-. The O2•- can react with Fe3+ to generate Fe2+, and raise H2O2 level via the superoxide dismutase. The generated Fe2+ and H2O2 can be fast converted into Fe3+ and •OH via Fenton reactions. The cyclic catalysis of intratumor Fe3+/2+ initiated by CDDP@GP@HMISN@LAC can be used for ferroptosis therapy of large tumors.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (52)

Show source-provided references
1. The cell biology of ferroptosis10.1038/s41580-024-00703-5 ↗
2. A guide to cell death pathways10.1038/s41580-023-00689-6 ↗
3. C. Wu, Z. Liu, Z. Chen, D. Xu, L. Chen, H. Lin, J. Shi, A nonferrous ferroptosis-like strategy for antioxidant inhibition–synergized nanocatalytic tumor therapeutics, Sci. Adv. 7(39) eabj8833.10.1126/sciadv.abj8833 ↗
4. An overview on mechanism, cause, prevention and multi-nation policy level interventions of dietary iron deficiency10.1080/10408398.2021.1879005 ↗
5. From the NIH: magnetic device tests for iron overload10.1001/jama.1985.03360080016003 ↗
6. Strategies for enhancing cancer chemodynamic therapy performance10.1002/EXP.20210238 ↗
7. Recent progress of metal-based nanomaterials with anti-tumor biological effects for enhanced cancer therapy10.1002/EXP.20220001 ↗
8. Structure–relaxivity mechanism of an ultrasmall ferrite nanoparticle T1 MR contrast agent: the impact of dopants controlled crystalline core and surface disordered shell10.1021/acs.nanolett.0c04574 ↗
9. An adenosine triphosphate-responsive autocatalytic fenton nanoparticle for tumor ablation with self-supplied H2O2 and acceleration of Fe(III)/Fe(II) conversion10.1021/acs.nanolett.8b03178 ↗
10. Small-sized gadolinium oxide based nanoparticles for high-efficiency theranostics of orthotopic glioblastoma10.1016/j.biomaterials.2020.119783 ↗
11. Tumor microenvironment-triggered MoS2@GA-Fe nanoreactor: a self-rolling enhanced chemodynamic therapy and hydrogen sulfide treatment for hepatocellular carcinoma10.1016/j.cej.2020.126888 ↗
12. A glucose/oxygen-exhausting nanoreactor for starvation- and hypoxia-activated sustainable and cascade chemo-chemodynamic therapy
13. Structural and molecular fusion MRI nanoprobe for differential diagnosis of malignant tumors and follow-up chemodynamic therapy10.1021/acsnano.2c12874 ↗
14. Blocking glutathione regeneration: inorganic NADPH oxidase nanozyme catalyst potentiates tumoral ferroptosis10.1016/j.nantod.2022.101574 ↗
15. A harmless–harmful switchable and uninterrupted laccase-instructed killer for activatable chemodynamic therapy10.1002/adma.202100114 ↗
16. An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers10.1038/s41467-022-29862-9 ↗
17. Good steel used in the blade: well-tailored type-I photosensitizers with aggregation-induced emission characteristics for precise nuclear targeting photodynamic therapy10.1002/advs.202100524 ↗
18. Triple-jump photodynamic theranostics: mno2 combined upconversion nanoplatforms involving a type-i photosensitizer with aggregation-induced emission characteristics for potent cancer treatment10.1002/adma.202103748 ↗
19. Bandgap-engineered germanene nanosheets as an efficient photodynamic agent for cancer therapy
20. A nanoscale trans-platinum(II)-Based supramolecular coordination self-assembly with a distinct anticancer mechanism10.1002/adma.202312488 ↗
21. Hydrazided hyaluronan/cisplatin/indocyanine green coordination nanoprodrug for photodynamic chemotherapy in liver cancer10.1016/j.carbpol.2021.118810 ↗
22. Laccase-based self-amplifying catalytic system enables efficient antibiotic degradation for sustainable environmental remediation10.1002/advs.202300210 ↗
23. Determination of reactive oxygen species generated in laccase catalyzed oxidation of wood fibers from Chinese fir (Cunninghamia lanceolata) by electron spin resonance spectrometry10.1016/j.biortech.2008.06.010 ↗
24. Laccase-mediated oxidation of small organics: bifunctional roles for versatile applications10.1016/j.tibtech.2013.04.002 ↗
25. Enhancing the production of hydroxyl radicals by pleurotus eryngii via quinone redox cycling for pollutant removal10.1128/AEM.02138-08 ↗
26. Aqueous and template-free synthesis of meso-macroporous polymers for highly selective capture and conversion of carbon dioxide10.1002/cssc.201701666 ↗
27. Drug delivery strategies for platinum-based chemotherapy10.1021/acsnano.7b04092 ↗
28. Controlled release of cisplatin from pH-thermal dual responsive nanogels10.1016/j.biomaterials.2013.07.092 ↗
29. Nanostructured Pt-doped tin oxide films: sol−gel preparation, spectroscopic and electrical characterization10.1021/cm001228o ↗
30. Metastable-phase platinum oxide for clarifying the Pt–O active site for the hydrogen evolution reaction10.1039/D2EE03351H ↗
31. High-resolution X-ray photoelectron spectroscopy of organometallic (C5H4SiMe3)3LnIII and [(C5H4SiMe3)3LnII]1– Complexes (Ln = Sm, Eu, Gd, Tb)10.1021/jacs.1c06980 ↗
32. Engineered bio-heterojunction confers extra- and intracellular bacterial ferroptosis and hunger-triggered cell protection for diabetic wound repair10.1002/adma.202305277 ↗
33. Laccase and its role in production of extracellular reactive oxygen species during wood decay by the brown rot basidiomycete Postia placenta10.1128/AEM.02929-09 ↗
34. A laccase with antiproliferative activity against tumor cells from an edible mushroom, white common Agrocybe cylindracea10.1016/j.phymed.2010.07.004 ↗
35. Microgel bioreactors for cancer cell targeting by pH-dependent generation of radicals10.1021/acs.molpharmaceut.9b00531 ↗
36. Nanoscintillator-mediated X-ray-triggered boosting transformation of Fe3+ into Fe2+ for Enhancing Tumor ferroptosis/immunotherapy10.1002/adfm.202301462 ↗
37. Comprehensively optimizing fenton reaction factors for antitumor chemodynamic therapy by charge-reversal theranostics10.1021/acsnano.3c03279 ↗
38. Amplification of lipid peroxidation by regulating cell membrane unsaturation to enhance chemodynamic therapy10.1002/anie.202218407 ↗
39. Facile synthesis of weakly ferromagnetic organogadolinium macrochelates-based T1-weighted magnetic resonance imaging contrast agents10.1002/advs.202205109 ↗
40. Reticular chemistry-enabled sonodynamic activity of covalent organic frameworks for nanodynamic cancer therapy10.1002/anie.202302146 ↗
41. Iron-siRNA nanohybrids for enhanced chemodynamic therapy via ferritin heavy chain downregulation10.1002/anie.202302255 ↗
42. Molecular bases of cellular iron toxicity12 1Guest Editor: mario Comporti 2This article is part of a series of reviews on “Iron and Cellular Redox Status.” the full list of papers may be found on the homepage of the journal10.1016/S0891-5849(02)00772-4 ↗
43. A lysosome-locating and acidic pH-activatable fluorescent probe for visualizing endogenous H2O2 in lysosomes10.1039/C7AN01280B ↗
44. Ferritinophagy mediated by oxidative stress-driven mitochondrial damage is involved in the polystyrene nanoparticles-induced ferroptosis of lung injury10.1021/acsnano.3c07255 ↗
45. Urchin-like ceria nanoparticles for enhanced gene therapy of osteoarthritis10.1126/sciadv.adf0988 ↗
46. Long noncoding RNA MAGI2-AS3 regulates the H2O2 level and cell senescence via HSPA810.1016/j.redox.2022.102383 ↗
47. Mitochondria and cancer10.1016/j.cell.2016.07.002 ↗
48. Hydroxyl radical is a significant player in oxidative DNA damage in vivo10.1039/D1CS00044F ↗
49. Biodegradable nanoscale coordination polymers for targeted tumor combination therapy with oxidative stress amplification10.1002/adfm.201908865 ↗
50. A “Closed-Loop” therapeutic strategy based on mutually reinforced ferroptosis and immunotherapy10.1002/adfm.202111784 ↗
51. Dual key co-activated nanoplatform for switchable MRI monitoring accurate ferroptosis-based synergistic therapy10.1016/j.chempr.2022.03.009 ↗
52. Targeted Manganese doped silica nano GSH-cleaner for treatment of Liver Cancer by destroying the intracellular redox homeostasis10.7150/thno.46771 ↗